![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, September 21, 2018 9:30:28 PM
Insightful as always:
“... the schedule got pulled in and this guy has stepped forward while the FDA and Precision Medicine are seriously in need of a credibility shot. There is a lot going on here folks. Why this, why him, why now? This is a big deal, IMO. He would not be doing this if that were not true, IMO. If I were in control at BIIB I would be sounding general quarters about now.”
You touch on all the pertinent points. We have our big guns out. 3 year results, precision biomarkers, HH, 2 trials at once...
I cannot resist making a bold prediction. I agree with what you say, but would add, you know who else is seriously in need of something here? Pretty much every BP, but BIIB is making their case obvious. So, I’ll go with them.
We dropped the “test bomb” off the coast at the AAIC. They didn’t surrender. So, we got a new funding source CF, trial approvals, began enrolling in Spain, additional patent approvals, Regulatory Pathfinders,...
They can see our guns and know they are outplayed. Biogen is a Gold Sponsor of the CTAD (highest level). They did not change their time slot nor issue a PR, like last time.
They will capitulate. Not at the conference - the CEO is not scheduled to be there at the presentation (and that’s a CEO announcement - ending a trial)...this has a much different tenor than last time. That was their strong arm approach. I believe this time they come in peace and are ready to report mediocre results, while letting us and our big guns have the spotlight. I think they want us to shine...it will make the case much more compelling for their shareholders when the big deal goes through. They are selling the acquisition to their investors now, imo. It’s their smartest move.
Know why our trial hasn’t appeared on the AUS registry yet? Cause it’s the Enola Gay...just doing a fly by, in case needed...but it shouldn’t be.
They will stand down the troops and prepare to sign the treaty. Treaties are good things. After you surrender, don’t forget, your enemy helps you REBUILD your forces and repair your damages! And, the FDA comes along with them. We can offer our pearl(s) of inestimable value. They can offer us a ton (and I mean ton!) of cash, help with FDA approvals, US trials, many trials, and infrastructure to manufacture, market, and sales/distribution for our products.
Together, with our pipeline, precision medicine, and their bankroll, we will be the largest BP globally (Don’t sell all your shares as soon as the deal is done!).
The AUS trial registry may come after a US trial approval, and they may both be registered under a combined name.
Biogen is smart, and greedy, and well resourced as a big pharmaceutical (labs, international markets, sales and marketing team) everything, all in place, and wants this deal. Missling has 10 guys and a drug which halts and in some cases reverses Alzheimer’s and will be approved for every CNS disease we get our hands on. Everybody knows this. We have hidden nothing - they know this works (skeptics, pardon my confidence), we all know this works, it’s safe, it’s the magic bullet - period. No more games. Very soon, we ride.
It’s over. And everyone benefits. Patients, caregivers, investors, both management teams, the biggest BP on earth, the FDA, and precision medicine.
No more battle stations. As WolfofMia quoted aptly earlier, “Victorious warriors win first and then go to war, while defeated warriors go to war first and then try to win.” Sun Tzu
But, eventually, no more war. Ecclesiastes 3
To every thing there is a season, and a time to every purpose under the heaven:
2 A time to be born, and a time to die; a time to plant, and a time to pluck up that which is planted;
3 A time to kill, and a time to heal; a time to break down, and a time to build up;
4 A time to weep, and a time to laugh; a time to mourn, and a time to dance;
5 A time to cast away stones, and a time to gather stones together; a time to embrace, and a time to refrain from embracing;
6 A time to get, and a time to lose; a time to keep, and a time to cast away;
7 A time to rend, and a time to sew; a time to keep silence, and a time to speak;
8 A time to love, and a time to hate; a time of war, and a time of peace.
Peace,
Bio
Recent AVXL News
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
- Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL • PR Newswire (US) • 05/03/2024 09:45:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 • GlobeNewswire Inc. • 05/02/2024 11:30:00 AM
- May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL • PR Newswire (US) • 04/26/2024 09:45:00 AM
- Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) • PR Newswire (US) • 04/19/2024 09:45:00 AM
- The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL • PR Newswire (US) • 04/16/2024 09:45:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/12/2024 09:45:00 AM
- Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference • GlobeNewswire Inc. • 04/11/2024 11:30:00 AM
- Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm • PR Newswire (US) • 04/09/2024 09:45:00 AM
- Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL • PR Newswire (US) • 04/05/2024 09:45:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 04/02/2024 09:45:00 AM
- Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 03/29/2024 09:45:00 AM
- Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL • PR Newswire (US) • 03/26/2024 09:45:00 AM
- Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM